[1] |
BELENKAYA T Y, HAN C, STANDLEY H J, et al.Pygopus encodes a nuclear protein essential for wingless/Wnt signaling[J].Development, 2002, 129(17):4089-4101.
|
[2] |
LIE D C, COLAMARINO S A, SONG H J, et al.Wnt signalling regulates adult hippocampal neurogenesis[J]. Nature, 2005, 437(7063):1370-1375.
|
[3] |
NUSSE R, VARMUS H E.Wnt genes[J].Cell, 1992, 69(7):1073-1087.
|
[4] |
NAIR M, NAGAMORI I, SUN P, et al.Nuclear regulator Pygo2 controls spermiogenesis and histone H3 acetylation[J].Dev Biol, 2008, 320(2):446-455.
|
[5] |
CARRERA I, JANODY F, LEEDS N, et al.Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13[J].Proc Natl Acad Sci U S A, 2008, 105(18):6644-6649.
|
[6] |
HORSLEY V.Epigenetics, Wnt signaling, and stem cells:the Pygo2 connection[J].J Cell Biol, 2009, 185(5):761-763.
|
[7] |
LIU R F, QIN X C, JI C Y, et al.Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and invasion in vitro and in vivo[J].Asian J Urol, 2015, 2(3):151-157.
|
[8] |
LIANG Y, WANG C X, CHEN A P, et al.Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors[J].J Cell Commun Signal, 2019, 13(1):75-84.
|
[9] |
ZHANG Z M, WU J F, LUO Q C, et al.Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway[J].Oncogene, 2016, 35(36):4787-4797.
|
[10] |
ZHOU C F, ZHANG Y, DAI J, et al.Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4 me3 and promotion of MLL1/MLL2 complex recruitment[J].Sci Rep, 2016, 6:22066.
|
[11] |
KATOH M, KATOH M.WNT signaling pathway and stem cell signaling network[J].Clin Cancer Res, 2007, 13(14):4042-4045.
|
[12] |
ZHANG S, LI J, LIU P G, et al.Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression[J].Oncotarget, 2015, 6(13):11074-11086.
|
[13] |
MOGHBELI M, ABBASZADEGAN M R, FARSHCHIAN M, et al.Association of Pygo2 and EGFR in esophageal squamous cell carcinoma[J].Med Oncol, 2013, 30(2):516.
|
[14] |
TALLA S B, BREMBECK F H.The role of Pygo2 for Wnt/β-catenin signaling activity during intestinal tumor initiation and progression[J].Oncotarget, 2016, 7(49):80612-80632.
|
[15] |
LIU Y, DONG Q Z, WANG S, et al.Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer[J].BMC Cancer, 2013, 13:346.
|
[16] |
XIE Y Y, MO C L, CAI Y H, et al.Pygo2 regulates adiposity and glucose homeostasis via β-catenin-axin2-gsk3β signaling pathway[J].Diabetes, 2018, 67(12):2569-2584.
|
[17] |
CHEN J K, LUO Q C, YUAN Y Y, et al.Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion[J].Mol Cell Biol, 2010, 30(24):5621-5635.
|
[18] |
葛少钦, GRIFIN J, 刘丽华, 等.特发性少精子症和无精子症与Pygo2基因蛋白编码区SNPs的相关性[J].遗传, 2013, 35(5):616-622.GE S Q, GRIFIN J, LIU L H, et al.Association of single nucleotide polymorphisms (SNPs) in Pygo2 coding gene with idiopathic oligospermia and azoospermia[J].Hereditas (Beijing), 2013, 35(5):616-622.(in Chinese)
|
[19] |
BETTEGOWDA A, WILKINSON M F.Transcription and post-transcriptional regulation of spermatogenesis[J].Philos Trans R Soc Lond B Biol Sci, 2010, 365(1546):1637-1651.
|
[20] |
LU X, PAN X L, WU C J, et al.An in vivo screen identifies PYGO2 as a driver for metastatic prostate cancer[J].Cancer Res, 2018, 78(14):3823-3833.
|
[21] |
KAO K R, POPADIUK P, THOMS J, et al.PYGOPUS2 expression in prostatic adenocarcinoma is a potential risk stratification marker for PSA progression following radical prostatectomy[J].J Clin Pathol, 2018, 71(5):402-411.
|
[22] |
CARLSEN E, GIWERCMAN A, KEIDING N, et al.Evidence for decreasing quality of semen during past 50 years[J].BMJ, 1992, 305(6854):609-613.
|
[23] |
GE S Q, GRIFIN J, LIU L H, et al.Associations of single nucleotide polymorphisms in the Pygo2 coding sequence with idiopathic oligospermia and azoospermia[J].Genet Mol Res, 2015, 14(3):9053-9061.
|
[24] |
FIEDLER M, SÁNCHEZ-BARRENA M J, NEKRASOV M, et al.Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex[J].Mol Cell, 2008, 30(4):507-518.
|
[25] |
LI H T, ILIN S, WANG W, et al.Molecular basis for site-specific read-out of histone H3K4 me3 by the BPTF PHD finger of NURF[J].Nature, 2006, 442(7098):91-95.
|
[26] |
CANTÙ C, VALENTA T, HAUSMANN G, et al.The Pygo2-H3K4 me2/3 interaction is dispensable for mouse development and Wnt signaling-dependent transcription[J].Development, 2013, 140(11):2377-2386.
|
[27] |
LI Q L, LI Y W, GU B N, et al.Akt phosphorylates Wnt coactivator and chromatin effector Pygo2 at serine 48 to antagonize its ubiquitin/proteasome-mediated degradation[J].J Biol Chem, 2015, 290(35):21553-21567.
|
[28] |
BROWN T C, NICOLSON N G, KORAH R, et al.BCL9 upregulation in adrenocortical carcinoma:a novel Wnt/β-catenin activating event driving adrenocortical malignancy[J].J Am Coll Surg, 2018, 226(6):988-995.
|
[29] |
CANTÙ C, FELKER A, ZIMMERLI D, et al.Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling[J].Genes Dev, 2018, 32(21-22):1443-1458.
|
[30] |
ZHANG X L, YAN H L, WANG K, et al.Goat CTNNB1:mRNA expression profile of alternative splicing in testis and association analysis with litter size[J].Gene, 2018, 679:297-304.
|
[31] |
ZHANG H, HUANG H, FENG X, et al.Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells[J].Theranostics, 2020, 10(3):1046-1059.
|
[32] |
SANCHEZ A, XU L, PIERCE J L, et al.Identification of testicular cancer driver genes by a cross-species comparative oncology approach[J].Andrology, 2019, 7(4):545-554.
|
[33] |
HVBNER K, GRASSME K S, RAO J, et al.Wnt signaling positively regulates endothelial cell fate specification in the Fli1a-positive progenitor population via Lef1[J].Dev Biol, 2017, 430(1):142-155.
|
[34] |
SANTIAGO L, DANIELS G, WANG D W, et al.Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment[J].Am J Cancer Res, 2017, 7(6):1389-1406.
|
[35] |
MANCINI M, SOVERINI S, GUGLIOTTA G, et al.Chibby 1:a new component of β-catenin-signaling in chronic myeloid leukemia[J].Oncotarget, 2017, 8(50):88244-88250.
|
[36] |
IGBINIGIE E, GUO F B, JIANG S W, et al.Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma[J]. Clin Chim Acta, 2019, 488:226-234.
|